Toleranzia AB
TOL | FN
Overview
Corporate Details
- ISIN(s):
- SE0007438577 (+1 more)
- LEI:
- 529900ARVN1D3A4CHI81
- Country:
- Sweden
- Address:
- Arvid Wallgrens backe 20, 413 46 Göteborg
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Toleranzia AB develops immune tolerance-inducing treatments for autoimmune diseases. Their therapies aim to restore immune system balance.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-04 | Thomas Eldered | Other | Sell | 12,000,000 | 5,100,000.00 SEK |
| 2025-04-03 | Thomas Eldered | Other | Sell | 23,764,705 | 10,099,999.62 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Lidds AB | Sweden | LIDDS | |
|
Lifecare ASA | Norway | LIFE | |
|
Lineage Cell Therapeutics Inc. | Israel | LCTX | |
|
Lipidor AB | Sweden | LIPI | |
|
Lipigon Pharmaceuticals AB | Sweden | LPGO | |
|
Lipum AB | Sweden | LIPUM | |
|
Lonza Group AG | Switzerland | LONN | |
|
LYSOGENE | France | LYS | |
|
Lytix Biopharma AS | Norway | LYTIX | |
|
MaaT Pharma | France | MAAT |